Benzinga’s Top Pre-Market Losers

Benzinga’s Top Pre-Market Losers

Nektar Therapeutics (NASDAQ: NKTR) dipped 24.19% to $ 10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

Zoltek Companies (NASDAQ: ZOLT) shares dropped 10.05% to $ 16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $ 16.75 per share.

J. C. Penney Company (NYSE: JCP) shares fell 8.54% to $ 9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $ 9.65 per share.

Accenture (NYSE: ACN) dipped 4.18% to $ 72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $ 4.42 to $ 4.54 per share, versus analysts’ expectations of $ 4.50 per share.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Benzinga – Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals


Uncategorized

Leave a Reply

Your email address will not be published.